Published in Thromb Diath Haemorrh on January 31, 1966
Concentration of plasminogen and antiplasmin in plasma and serum. J Clin Pathol (1981) 1.00
Subacute massive pulmonary embolism treated with plasminogen and streptokinase. Thorax (1983) 0.89
Clinical experience with brinase. J Clin Pathol (1972) 0.75
Observations on NUTRITION IN RELATION TO ANAEMIA. Br Med J (1933) 2.57
The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor. J Exp Med (1969) 2.39
Attitudes of patients to clinical teaching. Br J Med Educ (1967) 2.28
Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors. J Clin Invest (1969) 2.14
THE RATE OF ABSORPTION OF IODIDE AND GLYCINE FROM THE GASTRO-INTESTINAL TRACT IN NORMAL PERSONS AND IN DISEASE CONDITIONS. J Clin Invest (1935) 1.92
Postgraduate medical degrees of the University of Aberdeen, 1931-69. Scott Med J (1970) 1.64
Plasma fibrinogen and plasminogen levels in health and in ischaemic heart disease. J Clin Pathol (1966) 1.55
Venous thrombosis following strokes. Lancet (1972) 1.46
Familial thrombosis: inherited deficiency of antithrombin III. Br Med J (1978) 1.40
Macrocytic Anaemia of Pregnancy and the Puerperium. Br Med J (1943) 1.38
Studies on the blood fibrinolytic enzyme system following acute myocardial infarction. Clin Sci (1967) 1.26
Further medical education of Aberdeen graduates 1956-58. Br J Med Educ (1969) 1.18
Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. Br Med J (1976) 1.15
The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor). Br J Haematol (1971) 1.12
A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction. Lancet (1973) 1.11
Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease. Br Med J (1962) 1.10
The relationship between platelet aggregation and time interval after venepuncture. Thromb Diath Haemorrh (1974) 1.08
Present employment of University of Aberdeen medical graduates, 1956-58. Lancet (1969) 1.06
The inhibition of urokinase by alpha 2 -macroglobulin. Clin Sci (1973) 0.97
Studies on the fibrinolytic enzyme system in obesity. J Clin Pathol (1966) 0.94
The metabolism of Plasmodium berghei, the malaria parasite of rodents. 2. An effect of mepacrine on the metabolism of glucose by the parasite separated from its host cell. Biochem J (1961) 0.93
Evaluation of diagnostic significance of certain symptoms and physical signs in anaemic patients. Br Med J (1969) 0.92
Inhibitors of the fibrinolytic enzyme system in renal disease. Clin Sci (1970) 0.92
Psychogenic purpura. Br Med J (1971) 0.91
Effect of oestriol on platelet adhesiveness and fibrinolysis in men. Lancet (1966) 0.91
Effect of exercise on platelet count, adhesion, and aggregation. Acta Haematol (1974) 0.91
Deep venous thrombosis of the legs after strokes: Part 2-Natural history. Br Med J (1976) 0.90
Factors influencing the prognosis in myelomatosis. Postgrad Med J (1971) 0.90
Platelet adhesiveness, coagulation, and fibrinolytic activity in obesity. J Clin Pathol (1972) 0.90
High incidence of myelomatosis in North-East Scotland. Scott Med J (1973) 0.90
Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre-eclampsia. Br J Obstet Gynaecol (1976) 0.90
The inhibition of tissue activator and urokinase by human plasma. Thromb Haemost (1982) 0.88
Methotrexate and the platelet count. Br J Cancer (1968) 0.88
Coagulation and fibrinolysis in thyroid disease. Acta Haematol (1978) 0.87
Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein. Br Med Bull (1978) 0.87
The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastases. J Clin Pathol (1971) 0.86
The inhibition by plasma of urokinase and tissue activator-induced fibrinolysis in pregnancy and the puerperium. Thromb Haemost (1983) 0.86
Arcus senilis and coronary artery disease. Am Heart J (1965) 0.85
Studies on an inhibitor of plasminogen activators in human platelets. Br J Haematol (1974) 0.85
The contribution of plasma protease inhibitors to antiplasmin activity in man. Clin Sci Mol Med (1976) 0.84
Blood levels of proteinase inhibitors in pre-eclampsia. Br J Obstet Gynaecol (1983) 0.83
Inhibitors of plasminogen activation in human blood. Br J Haematol (1976) 0.83
Blood levels of proteinase inhibitors in pregnancy. Br J Obstet Gynaecol (1982) 0.83
The action of antithrombin III on plasmin and activators of plasminogen. Biochim Biophys Acta (1975) 0.82
Changes in protease inhibitors after acute myocardial infarction. J Clin Pathol (1976) 0.82
Arterio-venous differences in the components of the fibrinolytic enzyme system. Thromb Diath Haemorrh (1966) 0.81
The thyroid and fibrinolysis. Br Med J (1967) 0.81
C1 inactivator level in pregnancy. Thromb Res (1982) 0.80
The influence of the platelet count on the incidence of thrombotic and haemorrhagic complications in polycythaemia vera. Postgrad Med J (1970) 0.80
The influence of alpha-1-antitrypsin on plasmin, urokinase and Hageman factor cofactor. Biochim Biophys Acta (1974) 0.80
The effect of age on the fibrinolytic enzyme system. J Clin Pathol (1974) 0.80
Urokinase in iliofemoral venous thrombosis. Br J Surg (1969) 0.79
Properties of a partially purified preparation of a circulating plasminogen activator. Thromb Res (1976) 0.79
The effect of age upon the coagulation system. J Clin Pathol (1974) 0.77
Platelet adhesiveness and fibrinolysis after recent cerebro-vascular accidents and their relationship with subsequent deep venous thrombosis of the legs. Thromb Haemost (1976) 0.77
The fibrinolytic system in pre-eclampsia. J Clin Pathol (1984) 0.77
The iron-deficiency anaemia of late infancy. Arch Dis Child (1937) 0.77
Haemoglobin Levels of the Poor Classes in Aberdeen. Br Med J (1944) 0.76
The effect of prolonged exercise on the components of the blood fibrinolytic enzyme system. J Physiol (1968) 0.76
The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness. Atherosclerosis (1975) 0.76
An evaluation of the diagnostic significance of some symptoms and physical signs in chronic iron-deficiency anaemia. Proc Nutr Soc (1969) 0.76
Changes in coagulation factors following acute myocardial infarction in man. Haemostasis (1976) 0.76
The influence of the polyphenols of cider on plasmin and plasminogen activators. Br J Haematol (1985) 0.76
Origin and employment of the medical graduates of the University of Aberdeen 1931-69. Br Med J (1970) 0.75
Effect of local exercise and vessel occlusion on fibrinolytic activity. J Clin Pathol (1977) 0.75
Thrombocytosis following thrombocytopenia in man. Postgrad Med J (1969) 0.75
Biochemistry of the plasmin system. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.75
The fibrinolytic enzyme system in hypertension. J Clin Pathol (1973) 0.75
Fibrinolytic capacity of arm and leg veins after femoral shaft fracture and acute myocardial infarction. Br Med J (1975) 0.75
NUTRITIONAL IRON-DEFICIENCY ANAEMIA: WITH SPECIAL REFERENCE TO PREVALENCE AND AGE AND SEX INCIDENCE. Br Med J (1935) 0.75
Fibrinolysis in leukaemia. J Clin Pathol (1968) 0.75
Fibrinolytic activity in malignant disease. J Clin Pathol (1975) 0.75
Effect of low-density lipoprotein preparations on plasmin. Clin Sci (1973) 0.75
Pernicious anaemia. Nurs Times (1975) 0.75
Studies on the blood fibrinolytic system in congestive cardiac failure. Clin Sci (1973) 0.75
The fibrinolytic enzyme system in anorexia nervosa. Acta Haematol (1976) 0.75
Coagulant activity of the scorpion venoms Palamneus gravimanus and Leiurus quinquestriatus. Toxicon (1974) 0.75
Proceedings: The contribution of individual protease inhibitors to plasma antiplasmin activity. Thromb Diath Haemorrh (1975) 0.75
Relationships between the haemostatic, complement and kinin-forming systems. Br J Haematol (1973) 0.75
Proceedings: Studies on circulating plasminogen activator. Thromb Diath Haemorrh (1975) 0.75
Platelet function after the administration of chlorpromazine to human subjects. Haemostasis (1976) 0.75
The effect of chlorpromazine and antihistamines on human blood platelets in vitro and in vivo. Bibl Anat (1973) 0.75
The influence of haemoglobin on the fibrinolytic enzyme system. Scand J Haematol (1973) 0.75
Note on the Costello-Comrey Anxiety Scale (CCAS). Psychol Rep (1971) 0.75
ANAEMIA IN POOR CLASS WOMEN. Br Med J (1936) 0.75
In vitro studies on a proteolytic enzyme from Aspergillus Oryzae (protease I). Thromb Diath Haemorrh (1968) 0.75
Studies on the clot-promoting effect of skin. J Lab Clin Med (1969) 0.75